Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 572 All time
- Disclosed funding
- $283.5B 494 disclosed amounts
- Median round
- $126M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| B BasetenCompany profile Builds systems software for AI applications, focusing on inference and model deployment Builds systems software for AI applications, focusing on inference and model deployment | $300M | Series ESeries C+ | AI | United States | Investors | |
Mews provides hospitality software for revenue and operational workflows. | $300M | Series DSeries C+ | Travel tech | Netherlands | Investors | |
| L LiveKitCompany profile Developer of infrastructure software for real-time AI voice and video applications Developer of infrastructure software for real-time AI voice and video applications | $100M | Series CSeries C+ | AI | United States | Investors | |
| D D-OrbitCompany profile D-Orbit provides orbital transport, satellite deployment and infrastructure services for commercial and institutional space missions. D-Orbit provides orbital transport, satellite deployment and infrastructure services for commercial and institutional space missions. | Undisclosed | Series D participation with secondary share purchasesSeries C+ | Space tech | Italy | Investors | |
| Z Provides real-money payment infrastructure for games and apps | $40M | Series CSeries C+ | Media & gaming | United States | Investors | |
| C Provides cyber-physical systems protection platform | $150M | Series FSeries C+ | Cybersecurity | United States | Investors | |
Corxel PharmaceuticalsCompany profile Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension. Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension. | ≤$287M | Series D1Series C+ | Biotech | China | Investors | |
DatarailsCompany profile Datarails provides financial planning, analysis and cash-management software for finance teams. Datarails provides financial planning, analysis and cash-management software for finance teams. | $70M | Series CSeries C+ | Fintech | United States | Investors | |
| P Provides human-led, AI-enhanced language learning platform | $150M | Series DSeries C+ | Edtech | United States | Investors | |
| O Provides AI-powered medical search engine for clinicians | $250M | Series DSeries C+ | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
Isomorphic Labs, Northwood Space, Kalshi
44rounds5led - 2General Catalyst
Mercor, Clara, Nominal
44rounds1led - 3Sequoia Capital
Isomorphic Labs, LangChain, Nominal
43rounds8led - 4Lightspeed
Payhawk, Nominal, Fractile
39rounds7led - 5NVIDIA
Agile Robots, Mercor, fal
36rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.